[go: up one dir, main page]

HK40074885B - Anti-c10orf54 antibodies and uses thereof - Google Patents

Anti-c10orf54 antibodies and uses thereof

Info

Publication number
HK40074885B
HK40074885B HK42022061087.7A HK42022061087A HK40074885B HK 40074885 B HK40074885 B HK 40074885B HK 42022061087 A HK42022061087 A HK 42022061087A HK 40074885 B HK40074885 B HK 40074885B
Authority
HK
Hong Kong
Prior art keywords
c10orf54 antibodies
c10orf54
antibodies
Prior art date
Application number
HK42022061087.7A
Other languages
Chinese (zh)
Other versions
HK40074885A (en
Inventor
J·利平科特
E·T·H·凡德霍斯特
S·Y·金
L·G·普雷斯塔
J-W·特尼桑
Original Assignee
皮埃尔法布雷医药公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 皮埃尔法布雷医药公司 filed Critical 皮埃尔法布雷医药公司
Publication of HK40074885A publication Critical patent/HK40074885A/en
Publication of HK40074885B publication Critical patent/HK40074885B/en

Links

HK42022061087.7A 2014-12-11 2018-11-07 Anti-c10orf54 antibodies and uses thereof HK40074885B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62/090,880 2014-12-11

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK18114195.4A Addition HK1255067A1 (en) 2014-12-11 2015-12-11 Anti-c10orf54 antibodies and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK18114195.4A Division HK1255067A1 (en) 2014-12-11 2015-12-11 Anti-c10orf54 antibodies and uses thereof

Publications (2)

Publication Number Publication Date
HK40074885A HK40074885A (en) 2023-01-13
HK40074885B true HK40074885B (en) 2025-08-08

Family

ID=

Similar Documents

Publication Publication Date Title
EP3229838A4 (en) Anti-c10orf54 antibodies and uses thereof
IL251248A0 (en) Anti-interleukin-33 antibodies and uses thereof
ZA201605894B (en) Anti-egfrviii antibodies and uses thereof
EP3240569A4 (en) Anti-cd47 antibodies and uses thereof
EP3215175A4 (en) Anti-pro/latent-myostatin antibodies and uses thereof
EP3215538A4 (en) Anti-cd39 antibodies and uses thereof
EP3237450A4 (en) Anti-mertk agonistic antibodies and uses thereof
GB201403875D0 (en) Novel antibodies and uses thereof
EP3149037A4 (en) Anti-her2 glycoantibodies and uses thereof
GB201413913D0 (en) Novel antibodies and uses thereof
ZA201701663B (en) Anti-il-25 antibodies and uses thereof
EP3107569A4 (en) Anti-acth antibodies and use thereof
EP3126398A4 (en) Bi-specific antibodies and uses thereof
EP3197915A4 (en) Humanized anti-hepcidin antibodies and uses thereof
EP3177650A4 (en) Anti-ceramide antibodies
EP3204411A4 (en) Anti-tau antibody and uses thereof
EP3209686A4 (en) Monoclonal anti-gpc-1 antibodies and uses thereof
EP3149039B8 (en) Anti-neurotensin antibodies and uses thereof
EP3233919A4 (en) Dicam-specific antibodies and uses thereof
EP3209697A4 (en) Fn14-binding proteins and uses thereof
HK40042519B (en) Antibodies, uses and methods
HK40074885B (en) Anti-c10orf54 antibodies and uses thereof
CA3265373A1 (en) Anti-acth antibodies and use thereof
HK1238662A1 (en) Anti-tenascin c antibodies and uses thereof
EP3233107A4 (en) Nbp158 and uses thereof